Allergan to cut 1,500 employees in restructuring

NEW YORK — Botox maker Allergan Inc. will cut 13 percent of its workforce to become more efficient as it fights a hostile takeover bid by Valeant Pharmaceuticals International Inc.

The company said it plans to trim about 1,500 employees and 250 vacant positions, and that the restructuring will yield pretax savings of about $475 million in 2015.


It announced the cuts Monday, the same day it reported second-quarter earnings grew 16 percent to $417.2 million.

‘‘Today’s results demonstrate that we’re clearly on the right path,’’ CEO David Pyott told analysts. ‘‘The actions announced today will only accelerate our trajectory.’’

Get Talking Points in your inbox:
An afternoon recap of the day’s most important business news, delivered weekdays.
Thank you for signing up! Sign up for more newsletters here

The drug maker also said that it has raised its forecast for adjusted 2014 earnings to between $5.74 and $5.80 per share. It expects Botox to deliver net sales ranging from $2.2 billion to $2.28 billion.

Associated Press

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of